Radical prostatectomy did not reduce all-cause or prostate-cancer mortality compared with observation among men with localized prostate cancer after 12 years of follow-up, according to a study published July 19 in the New England Journal of Medicine.  The results boost support for observation, and may allow men to avoid unnecessary biopsies and interventions.

United Pharmacy Partners of Suwanee, Ga., has signed a five-year agreement with Novation, a healthcare supply chain and contracting company, to offer PET radiopharmaceuticals.

While GEs second quarter 2012 operating earnings of $4 billion were up 7 percent from the second quarter of 2011, the operating earnings for its GE Healthcare unit dropped 2 percent to $694 million in the same comparable period.

The American Society for Radiation Oncology (ASTRO) has released a comprehensive book detailing the minimum recommended guidelines for radiation oncology practices as part of the societys Target Safely initiative.

The National Comprehensive Cancer Network (NCCN), with the support of the NCCN Foundation and Lung Cancer Alliance, has released the NCCN Guidelines for Patients for Lung Cancer Screening, as the latest addition to the library of NCCN Guidelines for Patients, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).

GE Healthcare has received FDA 510(k) clearance of its new cardiac imaging platform, the Discovery CT750 HD FREEdom Edition.

The Olympic Games dont get started in London until next week, but theres already a bit of a competitive spirit in the top medical imaging headlines from this week. Which hospital ranks number one in the U.S.? Can the iPad stand up to secondary-class LCD monitors when viewing MRIs? Which enterprise imaging strategy came out on top in a survey of providers?

White knights appear in many forms, but not often as a study in a medical journal. But the publication of a study this week in the Journal of the American Medical Association may be hailed for swooping in just in time to change the course of a public policy decision that, some neurologist say, would misalign incentives and ultimately harm patients if left as is.